N/A N=319 An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation
Intervertebral Disk Degeneration
Primary: Radiologic Fusion — 129; 121; 16; 20 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=440 Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
Helicobacter Pylori Infection
Primary: Number of Participants in Which H. Pylori Was Eradicated — 206; 191 participants — p=<0.05
Phase 3 N=481 Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
Metastatic Breast Cancer
Primary: Percentage of Participants With Progression or Death in Intent-to-Treat (ITT) Population — 69.4; 63.6 percentage of participants
Phase 2 N=18 Intravenous Allopurinol in Heart Failure
Congestive Heart Failure
Primary: Myocardial Creatine Kinase (CK) Flux Pre Intravenous Allopurinol Infusion — 2.07 umol/g/sec
N/A N=20 Cramer Sports Motion Tape and Low Back Pain EMG
Low Back Pain
Primary: Percent of Maximal Voluntary Isometric Contraction (%MVIC) — 226.41; 250.51; 162.47; 205.82 % of Max Voluntary Isometric Contraction
N/A N=34 Effectiveness of Biofreeze® on Shoulder Pain and In-office Exercise Performance
Shoulder Pain
Primary: Change From Baseline of American Shoulder and Elbow Surgeons (ASES) Questionnaire at 2 Weeks — 72.6; 68.75 units on a scale
Phase 3 N=52 Use of a Novel Fibrin Sealant in Total Knee Arthroplasty
Osteoarthritis · Intraoperative Bleeding
Primary: Primary--Percent Change of Pre- to Post-Operative Hemoglobin — 20.1; 22.5 Percent Change — p=0.2
N/A N=50 Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety
Depression · Anxiety
Primary: Number of Participants Meeting Depression Remission Criteria — 10; 15 participants
N/A N=60 Evaluation of Group Lifestyle Balance Maintenance Strategies
Diabetes
Primary: Change in Weight — 2.1; 0.2 pounds
N/A N=1,256 Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care
Colon Cancer · Lung Cancer · Prostate Cancer
Primary: Differences in Time to Documented Follow-up of a Red Flag Suggestive of Cancer — 104; 200; 144; 192 Days — p=<0.05
Phase 2 N=89 Efficacy and Safety Study of ESBA1008 Versus EYLEA®
Exudative Age-Related Macular Degeneration
Primary: Best-Corrected Visual Acuity (BCVA) Change From Baseline (No. of Letters) to Week 12 — 54.1; 55.6; 5.8; 6.9 letters
N/A N=4,021 South African Surgical Outcomes Study
Mortality Following Noncardiac Surgery
Primary: Mortality — 123 participants
Phase 1 N=60 A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C
Hepatitis C, Chronic
Primary: Feasibility of Peginterferon Alfa-2a Administration by Autoinjector — 11; 14; 49; 45 participants
Phase 3 N=78 Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide.
Chronic Obstructive Pulmonary Disease: COPD
Primary: Inspiratory Capacity (IC) Peak Value — 2.87; 2.94; 2.99; 2.85 Liters
N/A N=160 An Observational Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-myeloid Malignancy
Anemia
Primary: Percentage of Participants With an Increase of Greater Than or Equal to 1 Gram Per Decilitre in Hemoglobin Level at Week 8 — 67.96 percentage of participants